pH imbalance in astrocytes may lead to Alzheimer’s disease
The researchers found that 10 of the 100 most frequently down-regulated genes were connected with proton flow in the cell...
List view / Grid view
The researchers found that 10 of the 100 most frequently down-regulated genes were connected with proton flow in the cell...
Scientists have identified an easy upgrade for the technology that would lead to more accurate gene editing...
The team found that astrocytes inhibit growth of precursor cells that become myelin, and speed up the neural network in the brain...
Researchers have discovered that FFW and Sorafenib used together could reduce the growth of Sorafenib resistant hepatocellular carcinoma tumours...
The team studied chemical compositions in detail and from one strain of bacteria several antibiotically active chemical substances were discovered...
Mice with pancreatic cancer that were treated with CBD alongside chemotherapy, survived almost three times longer than those treated with chemotherapy alone...
Previous studies have suggested that a gene therapy drug may be used to treat ALS...
A new drug has been developed to help prevent attacks of hereditary angioedema and at the same offer patients a convenient administration...
A derivative of turmeric could be used in eye drops to treat the early stages of glaucoma...
ATPliteTM and ATPlite 1step are robust, rapid, high-throughput luminescence assays used to assess a compound’s druggability.
In today’s modern world, data is everywhere. This eBook will guide you through the steps of how to achieve more with accurate data.
Quickly and easily quantitate immune checkpoint markers using a fraction of the sample volume required by traditional ELISAs...
In this video, Becky Allsopp from Sygnature Discovery talks about Drug Discovery Research and how she uses the Microplate Reader PHERAstar FSX for their research.
AlphaLISA® provides a robust assay that facilitates the design and development of antibody therapeutics.
This whitepaper explains how you can find ways to optimise the holistic preclinical development process...